[1] |
Chen JS, Li HS, Huang JQ, et al. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma[J]. Cancer Lett, 2016, 375(1):73-83. DOI: 10.1016/j.canlet.2016.02.043.
|
[2] |
Li SP, Xu HX, Yu Y, et al. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway[J]. Oncotarget, 2016, 7(27):42431-42446.DOI: 10.18632/oncotarget.9883.
|
[3] |
Guo J, Huang X, Wang H, et al. Celastrol induces autophagy by targeting AR/miR-101 in prostate cancer cells[J]. PLoS One, 2015, 10(10):e0140745. DOI: 10.1371/journal.pone.0140745.
|
[4] |
Zheng M, Jiang YP, Chen W, et al. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma[J]. Oncotarget, 2015, 6(9):6797-6810. doi: 10.18632/oncotarget
|
[5] |
Wang J, Ou J, Guo Y, et al. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer[J]. Br J Cancer, 2014, 111(1):112-124. DOI: 10.1038/bjc.2014.278.
|
[6] |
Jiang W, Gu W, Qiu R, et al. MiRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells[J]. Anticancer Agents Med Chem, 2016, 16(4):432-439. doi: 10.2174/1871520615666150507122142
|
[7] |
Guo F, Parker Kerrigan BC, Yang D, et al. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions[J]. J Hematol Oncol, 2014, 7:19. DOI: 10.1186/1756-8722-7-19.
|
[8] |
Zhao S, Zhang Y, Zheng X, et al. Loss of microRNA-101 promotes epithelial to mesenchymal transition in hepatocytes[J]. J Cell Physiol, 2015, 230(11):2706-2717. DOI: 10.1002/jcp.24995.
|
[9] |
陈斌, 沈顺利, 彭宝岗.微小RNA let-7a对CD133+肝癌干细胞增殖和转移的影响[J/CD].中华细胞与干细胞杂志(电子版), 2015, 5(3):44-47. DOI:10.3877/cma.j.issn.2095-1221. 2015.03.010.Chen B, Shen SL, Peng BG. Effect of microRNA let-7a on the proliferation and metastasis of CD133+ liver cancer stem cells[J/CD]. Chin J Cell Stem Cell(Electr Edit), 2015, 5(3):44-47. DOI: 10.3877/cma.j.issn.2095-1221.2015.03.010.
|
[10] |
Guo F, Cogdell D, Hu L, et al. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma[J]. Oncol Rep, 2014, 31(5):2021-2028. DOI: 10.3892/or.2014.3106.
|
[11] |
Bao RF, Shu YJ, Hu YP, et al. MiR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma[J]. Oncotarget, 2016, 7(16):22339-22354. DOI: 10.18632/oncotarget.7970.
|
[12] |
Wei X, Tang C, Lu X, et al. MiR-101 targets DUSP1 to regulate the TGF-beta secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma[J]. Oncotarget, 2015, 6(21):18389-18405. doi: 10.18632/oncotarget
|
[13] |
Qian K, Liu G, Tang Z, et al. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2[J]. Arch Biochem Biophys, 2017, 615: 1-9. DOI: 10.1016/j.abb.2016.12.011.
|
[14] |
Hu H, He Y, Wang Y, et al. MicorRNA-101 silences DNA-PKcs and sensitizes pancreatic cancer cells to gemcitabine[J]. Biochem Biophys Res Commun, 2017, 483(1) : 725-731. DOI: 10.1016/j.bbrc.2016.12.074.
|
[15] |
Ye Z, Yin S, Su Z, et al. Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2[J]. Oncotarget, 2016, 7(25):37524-37535. DOI: 10.18632/oncotarget.6852.
|
[16] |
Zhao H, Tang H, Huang Q, et al. MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma[J]. Am J Cancer Res, 2016, 6(11):2575-2586. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126274/
|
[17] |
Tang B, Liang X, Tang F, et al. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma[J]. Int J Oncol, 2015, 47(6):2208-2216. DOI: 10.3892/ijo.2015.3214.
|
[18] |
Tang B, Tang F, Li B, et al. High USP22 expression indicates poor prognosis in hepatocellular carcinoma[J]. Oncotarget, 2015, 6(14):12654-12667. doi: 10.18632/oncotarget
|
[19] |
Zhai R, Tang F, Gong J, et al. The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis[J]. Onco Targets Ther, 2016, 9:6987-6998. doi: 10.2147/OTT
|